Reparative injections, also known as Human Cellular Tissue Products, represent cutting-edge regenerative techniques that harness the potential of the body’s natural healing mechanisms. These injections include undifferentiated cells that have the unique ability to differentiate into various cell types, promoting tissue repair and rebuilding properties. Another type of reparative injection has tiny extracellular vesicles released by cells that contain bioactive molecules, such as proteins and genetic material, capable of influencing cellular communication and restorative characteristics. When administered through injections, either alone or in combination, these therapies aim to enhance the body’s reparative capacity. These injections can target damaged tissues and organs, potentially aiding in the treatment of conditions like osteoarthritis and neurodegenerative disorders. While research into these therapies is ongoing, proponents suggest that they may offer benefits such as reduced inflammation, improved tissue function, and accelerated healing.